News

Article

FDA Issues Guidance on Outsourcing Registration

The agency issues guidance for companies considering registering with FDA as an outsourcing facility.

 

FDA released guidance on Aug. 11, 2015 directed at companies that are considering registering with the agency as an outsourcing facility under section 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act).  The guidance is in response to questions the agency received from companies about which activities (e.g., drug compounding) would require a company to register as an outsourcing facility and, therefore, be subject to registration fees.

The FDA guidance gives more information about the regulatory impact of registering as an outsourcing facility, so companies may be better prepared to make the decision to register. FDA issued a separate guidance that details the process for registering. 

Source: FDA

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Related Content